Moffitt Cancer Center Executive Leadership
Vice President, Clinical Trials and Operations Excellence
Jay Lebsack is the Vice President of Clinical Trials and Operations Excellence at Moffitt Cancer Center. He is responsible for overseeing clinical trials operations and the project and process management office. Moffitt offers one of the largest portfolios of clinical trials in the nation with nearly 400 active treatment trials, over 1,200 patients accrued annually and 13,000 treatments provided each year. He is responsible for leading operations across the clinical trial life cycle, including timely and efficient study vetting and activation; safe patient-centered and effective delivery of treatments; coordination of trial progress and amendments; and a successful trial closeout.
Lebsack brings 20 years of experience to the role as an administrative leader in academic medicine, serving in leadership roles in clinical trials operations, systems and operations improvement, process excellence, project and implementation management, quality improvement, and analytics. He has a passion for problem-solving across research, clinical and administrative functions through the collaborative development of creative, sustained solutions.
Previously Lebsack was the senior director of Moffitt’s Process and Project Management Office. Prior to that, he was the director of Continuous Quality Improvement at the Nebraska Medical Center.
Lebsack was among the first certified Lean Six Sigma Black Belts and Master Black Belts in Healthcare in the United States. He is a certified scrum master and certified in Change Management (Change Acceleration Process). He completed a fellowship in quality and patient safety with the University HealthSystem Consortium (now Vizient). Lebsack was selected to serve as Moffitt’s administrative representative in the 2021-22 Advisory Board Fellowship for rising leaders. He holds a master’s degree in Industrial & Organizational Psychology from the University of Nebraska and a bachelor’s from Hastings College.